Local News

• Applied Biosystems reports fourth quarter financial results  Applied Biosystems reported net revenues of $609.0 million for the fourth quarter of fiscal 2008, an increase of 9% over the prior year quarter of $557.3 million. The net effect of foreign currency on net revenues was a favorable impact of approximately 5% compared to the prior year quarter.
  Applied Biosystems July 24, 2008  
• Invitrogen announces second quarter 2008 financial results  Invitrogen announced results for its second quarter ended June 30, 2008. Revenues for the second quarter were $368 million, an increase of 14.3 percent over the $322 million reported for the second quarter of 2007.
  Invitrogen Corporation July 24, 2008  
• Multithreaded supercomputer seeks software for data-intensive computing  Pacific Northwest National Laboratory and Cray Inc. lead a team that received $4 million to develop software for the newest breed of supercomputers to better tackle large networks of seemingly random data, applicable in internet security, power grid stability and complex biological networks.
  Pacific Northwest National Laboratory July 24, 2008  
• Celera reports fourth quarter and fiscal 2008 results  Celera reported net revenues of $43.4 million for the fourth quarter of fiscal 2008, compared to $10.2 million in the prior year quarter. Celera reported a net loss of $96.8 million compared to a net loss of $8.0 million for the prior year quarter.
  Celera Corporation July 23, 2008  
• Genzyme reports strong second-quarter 2008 Growth  Genzyme reported that revenue increased 25 percent to approximately $1.171 billion from $933.4 million in last year’s second quarter. Net income was $69.6 million compared with $83.8 million in the second quarter a year ago.
  Genzyme Corporation July 23, 2008  
• Merck announces fourth quarter 2008 dividend  The Board of Directors of Merck & Co. declared a quarterly dividend of $0.38 per share on the Company's common stock for the fourth quarter of 2008.
  Merck & Co., Inc. July 22, 2008  
• Medicare act extending longstanding reimbursement policy for brachytherapy seeds enacted  Theragenics announced favorable developments in Medicare reimbursement policies related to brachytherapy. On July 15, 2008, the Medicare Improvements for Patients and Providers Act of 2008 was enacted into law.
  Theragenics Corporation July 21, 2008  
• Senate Appropriations Committee approves $2 billion for FDA  The Senate Appropriations Committee unanimously passed an appropriations markup measure Thursday, providing the FDA with a $2.04 billion fiscal 2009 budget. This amount is $324.6 million more than the agency initially received for fiscal 2008.
  FDAnews July 21, 2008  
• Wyeth Pearl River Facility earns OSHA VPP Star; 2,000th workplace recognized in U.S.  Wyeth announced that its manufacturing and research facility in Pearl River, N.Y., has earned the highest recognition for workplace safety and health from the U.S. Department of Labor's Occupational Safety and Health Administration (OSHA): the Voluntary Protection Programs (VPP) "star."
  Wyeth July 21, 2008  
• Boston Scientific announces results for second quarter ended June 30, 2008  Boston Scientific announced financial results for the second quarter ended June 30, 2008, as well as guidance for net sales and earnings per share (EPS) for the third quarter of 2008. For the second quarter, the company achieved net sales of $2.024 billion.
  Boston Scientific Corporation July 21, 2008  

   (next 10 articles)